# Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.

> **NCT07303088** · NA · COMPLETED · sponsor: **University of Sfax** · enrollment: 52 (actual)

## Conditions studied

- Oxidative Stress Response
- Hemodialysis
- End Stage Kidney Disease (ESRD)

## Interventions

- **DIETARY_SUPPLEMENT:** Oral administration of L-carnitine 1000 Mg
- **DIETARY_SUPPLEMENT:** Oral administration of Coenzyme Q10 300Mg
- **OTHER:** placebo capsules

## Key facts

- **NCT ID:** NCT07303088
- **Lead sponsor:** University of Sfax
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-17
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07303088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07303088, "Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07303088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*